Literature DB >> 28449451

Malignant pleural mesothelioma: key determinants in tailoring the right treatment for the right patient.

Ori Wald1, David J Sugarbaker1.   

Abstract

Entities:  

Year:  2017        PMID： 28449451      PMCID： PMC5394047          DOI： 10.21037/jtd.2017.03.27

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  24 in total

1.  Radical pleurectomy/decortication followed by high dose of radiation therapy for malignant pleural mesothelioma. Final results with long-term follow-up.

Authors:  Emilio Minatel; Marco Trovo; Jerry Polesel; Tania Baresic; Alessandra Bearz; Giovanni Franchin; Carlo Gobitti; Imad Abu Rumeileh; Annalisa Drigo; Paolo Fontana; Vittore Pagan; Mauro G Trovo
Journal:  Lung Cancer       Date:  2013-10-27       Impact factor: 5.705

2.  Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection.

Authors:  David J Sugarbaker; Ritu R Gill; Beow Y Yeap; Andrea S Wolf; Marcelo C DaSilva; Elizabeth H Baldini; Raphael Bueno; William G Richards
Journal:  J Thorac Cardiovasc Surg       Date:  2013-02-21       Impact factor: 5.209

3.  Epithelial malignant pleural mesothelioma after extrapleural pneumonectomy: stratification of survival with CT-derived tumor volume.

Authors:  Ritu R Gill; William G Richards; Beow Y Yeap; Shin Matsuoka; Andrea S Wolf; Victor H Gerbaudo; Raphael Bueno; David J Sugarbaker; Hiroto Hatabu
Journal:  AJR Am J Roentgenol       Date:  2012-02       Impact factor: 3.959

4.  Survival after conservative (palliative) management of pleural malignant mesothelioma.

Authors:  N Merritt; C J Blewett; J D Miller; W F Bennett; J E Young; J D Urschel
Journal:  J Surg Oncol       Date:  2001-11       Impact factor: 3.454

5.  Clinical and pathological features of three-year survivors of malignant pleural mesothelioma following extrapleural pneumonectomy.

Authors:  David J Sugarbaker; Andrea S Wolf; Lucian R Chirieac; John J Godleski; Tamara R Tilleman; Michael T Jaklitsch; Raphael Bueno; William G Richards
Journal:  Eur J Cardiothorac Surg       Date:  2011-02-09       Impact factor: 4.191

6.  Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma.

Authors:  Marc de Perrot; Ronald Feld; Natasha B Leighl; Andrew Hope; Thomas K Waddell; Shaf Keshavjee; B C John Cho
Journal:  J Thorac Cardiovasc Surg       Date:  2015-10-19       Impact factor: 5.209

7.  The IASLC Mesothelioma Staging Project: Proposals for Revisions of the N Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma.

Authors:  David Rice; Kari Chansky; Anna Nowak; Harvey Pass; Hedy Kindler; Lynn Shemanski; Isabelle Opitz; Sergi Call; Seiki Hasegawa; Kemp Kernstine; Cansel Atinkaya; Federico Rea; Philippe Nafteux; Valerie W Rusch
Journal:  J Thorac Oncol       Date:  2016-09-26       Impact factor: 15.609

8.  The IASLC Mesothelioma Staging Project: Proposals for Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma.

Authors:  Anna K Nowak; Kari Chansky; David C Rice; Harvey I Pass; Hedy L Kindler; Lynn Shemanski; Andrea Billé; Robert C Rintoul; Hasan F Batirel; Charles F Thomas; Joseph Friedberg; Susana Cedres; Marc de Perrot; Valerie W Rusch
Journal:  J Thorac Oncol       Date:  2016-09-26       Impact factor: 15.609

9.  Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma.

Authors:  Lee M Krug; Harvey I Pass; Valerie W Rusch; Hedy L Kindler; David J Sugarbaker; Kenneth E Rosenzweig; Raja Flores; Joseph S Friedberg; Katherine Pisters; Matthew Monberg; Coleman K Obasaju; Nicholas J Vogelzang
Journal:  J Clin Oncol       Date:  2009-04-13       Impact factor: 44.544

10.  Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial.

Authors:  Rolf A Stahel; Oliver Riesterer; Alexandros Xyrafas; Isabelle Opitz; Michael Beyeler; Adrian Ochsenbein; Martin Früh; Richard Cathomas; Kristiaan Nackaerts; Solange Peters; Christoph Mamot; Alfred Zippelius; Carlo Mordasini; Clemens B Caspar; Katrin Eckhardt; Ralph A Schmid; Daniel M Aebersold; Oliver Gautschi; Wolfgang Nagel; Michael Töpfer; Jerome Krayenbuehl; Karin Ribi; Ilja Ciernik; Walter Weder
Journal:  Lancet Oncol       Date:  2015-11-02       Impact factor: 41.316
View more
  2 in total

Review 1.  Clinical diagnosis of malignant pleural mesothelioma.

Authors:  Andrea Bianco; Tullio Valente; Maria Luisa De Rimini; Giacomo Sica; Alfonso Fiorelli
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

2.  Polymeric films loaded with cisplatin for malignant pleural mesothelioma: a pharmacokinetic study in an ovine model.

Authors:  Luca Ampollini; Elisabetta Barocelli; Andrea Cavazzoni; Piergiorgio Petronini; Claudio Mucchino; Anna Maria Cantoni; Fabio Leonardi; Luigi Ventura; Stefano Barbieri; Paolo Colombo; Antonella Fusari; Paolo Carbognani; Michele Rusca; Fabio Sonvico
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.